Organization: Toronto Stock Exchange

Immunovaccine raises $11.2 million, gets TSX listing

Immunovaccine Inc is moving up from the TSX Venture Exchange to the Toronto Stock Exchange following a successful initial public offering (IPO) and private placement in September. The IPO and private placement raised $9.5 million and $1.7 million respectively for a total of $11.2 million. Immunovaccine will use the proceeds for additional R&D and clinical…

Sandvine Corp raises $40 million through IPO

Sandvine Corp has successfully raised $40 million with an initial public offering (IPO) on the Toronto Stock Exchange. The Waterloo ON-based company will realize about $13 million from the IPO which it will plow into R&D for its broadband network management equipment aimed at residential broadband service providers. The remaining two-thirds will go to Sandvine’s…

YM Biosciences issues $15-million floatation

YM Biosciences Inc has raised $15 million with the floatation of 3.75 million shares on the Toronto Stock Exchange and the Alternative Investment Market of the London Stock Exchange. The Mississauga-based YM will use the proceeds to expand and accelerate its product pipeline and commercial focus. The firm was formed to acquire the rights to…